Pet-yksikkö

Julkaisut 2011
Publications 2011

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Aalto K et al. Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer.
2 Alakurtti K et al. Reproducibility of striatal and thalamic dopamine D2 receptor binding using (11C)raclopride with high-resolution positron emission tomography.
3 Autio A et al. Mini-PEG spacering of VAP-1-targeting 68Ga-DOTAVAP-P1 peptide improves PET imaging of inflammation.
4 Avoranta ST et al. Securin identifies a subgroup of patients with poor outcome in rectal cancer treated with long-course (chemo) radiotherapy.
5 Bucci M. Lipotoxicity in Obesity and Coronary Artery Disease. Studies by PET, CT and MR.
6 Bucci M et al. Human obesity is characterized by defective fat storage and enhanced muscle fatty acid oxidation, and trimetazidine gradually counteracts these abnormalities .
7 Bucci M et al. Intrapericardial, but not extrapericardial, fat is an independent predictor of impaired hyperemic coronary perfusion in coronary artery disease.
8 Bäckman L et al. Effects of working-memory training on striatal dopamine release.
9 Carlsson M, Knuuti J. Myocardial Perfusion Single Photon Emission Computed Tomography and Positron Emission Tomography.
10 Fagerholm V et al. Alpha(2)-adrenoceptor regulation of blood glucose homeostasis.
11 Flotats A et al. Hybrid cardiac imaging: SPECT/CT and PET/CT. A joint position statement by the European Association of Nuclear Medicine (EANM), the European Society of Cardiac Radiology (ESCR) and the European Council of Nuclear Cardiology (ECNC). A joint position statement by the European Association of Nuclear Medicine (EANM), the European Society of Cardiac Radiology (ESCR) and the European Council of Nuclear Cardiology (ECNC).
12 Gaemperli O et al. Cardiac hybrid imaging.
13 Genders TS et al. A clinical prediction rule for the diagnosis of coronary artery disease: validation, updating, and extension.
14 Granholm P et al. On the decay of the Jp = 11/2-, T1/2 = 38.9 h isomer in 133Ba: search for the E5 transition and verification of the EC branch .
15 Hamm CW et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC).
16 Hannukainen JC et al. Liver and pancreatic fat content and metabolism in healthy monozygotic twins discordant physical activity .
17 Heinonen I. Comfortable at just below your critical speed: how is blood flow distribution coupled to muscle fibre recruitment during exercise?
18 Heinonen I et al. Skeletal muscle blood flow and oxygen uptake at rest and during exercise in humans: a pet study with nitric oxide and cyclooxygenase inhibition .
19 Heinonen I et al. Local heating, but not indirect whole body heating, increases human skeletal muscle blood flow.
20 Hirvonen J et al. Effects of insulin on brain glucose metabolism in impaired glucose tolerance .
21 Hirvonen J, Hietala J. Dysfunctional brain networks and genetic risk for schizophrenia: specific neurotransmitter systems.
22 Hirvonen J et al. Effects of antidepressant drug treatment and psychotherapy on striatal and thalamic dopamine D2/3 receptors in major depressive disorder studied with (11C)raclopride PET.
23 Huolman S et al. The effects of rivastigmine on processing speed and brain activation in patients with multiple sclerosis and subjective cognitive fatigue.
24 Hynninen J et al. Serum HE4 profile during primary chemotherapy of epithelial ovarian cancer.
25 Jokinen P. PET and MR Imaging in Parkinson's Disease Patients with Cognitive Impairment. A Study of Dopaminergic Dysfunction, Amyloid Deposition, Cortical Hypometabolism and Brain Atrophy.
26 Joutsa J et al. Extensive abnormality of brain white matter integrity in pathological gambling.
27 Järvelä JT et al. Kainic acid-induced neurodegeneration and activation of inflammatory processes in organotypic hippocampal slice cultures: Treatment with cyclooxygenase-2 inhibitor does not prevent neuronal death.
28 Kajander SA et al. Clinical value of absolute quantification of myocardial perfusion with 15 O-water in coronay artery disease .
29 Kalliokoski KK et al. Differential glucose uptake in quadriceps and other leg muscles during one-legged dynamic submaximal knee-extension exercise.
30 Kalliokoski T et al. Imaging of insulitis in NOD mice with IL-2-Gd-DTPA and 1.5 T MRI.
31 Karlsson H et al. No association between serotonin 5-HT 1A receptors and spirituality among patients with major depressive disorders or healthy volunteers.
32 Kaskinoro K et al. Wide inter-individual variability of bispectral index and spectral entropy at loss of consciousness during increasing concentrations of dexmedetomidine, propofol, and sevoflurane.
33 Kaufmann PA, Knuuti J. Ionizing radiation risks of cardiac imaging: estimates of the immeasurable.
34 Kauhanen S et al. Complementary roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in medullary thyroid cancer.
35 Kemppainen J et al. Reversible brain hypometabolism associated with central nervous system systemic lupus erythematosus.
36 Kiviniemi TO et al. Cold pressor test safety - The incidence of vasovagal reactions .
37 Knuuti J. Are coronary plaque characteristics on computed tomography angiography associated with myocardial perfusion?
38 Knuuti J , Saraste A . Hybrid SPECT-CT and PET-CT: Current concepts and development .
39 Koivunen J et al. Amyloid PET imaging in mild cognitive impairment patients: a two year follow-up study.
40 Koivuviita N . Vascular Function in Chronic Kidney Disease and in Renovascular Disease .
41 Koivuviita N et al. The effect of revascularization of atherosclerotic renal artery stenosis on coronary flow reserve and peripheral endothelial function .
42 Koskenvuo JW et al. Evidence of diminished coronary flow in pulmonary hypertension - explaining angina pectoris in this patient group?
43 Kronström K et al. Personality traits and recovery from major depressive disorder.
44 Kwon MS et al. GSM mobile phone radiation suppresses brain glucose metabolism.
45 Laitala VS et al. Shorter adult stature increases the impact of risk factors for cognitive impairment: a comparison of two Nordic twin cohorts.
46 Laitala VS et al. Association and causal relationship of midlife obesity and related metabolic disorders with old age cognition.
47 Landor SK et al. Hypo- and hyperactivated Notch signaling induce a glycolytic switch through distinct mechanisms.
48 Lee MS et al. The effect of age on motor deficits and cerebral glucose metabolism of Parkinson's disease.
49 Lill J et al. Ion beam analyses of bark and wood in environmental studies.
50 Lind A et al. Cognitive and neuropsychological outcomes at 5 years of age in preterm children born in the 2000s.
51 Lind A et al. Associations between regional brain volumes at term-equivalent age and development at 2 years of age in preterm children.
52 Lindholm P et al. PET imaging of blood flow and glucose metabolism in localized musculoskeletal tumors of the extremities.
53 Lindroos MM et al. Mitochondrial diabetes is associated with insulin resistance in subcutaneous adipose tissue but not with increased liver fat content.
54 Lönnroth T et al. Activities of the 7Be and 137Cs nuclides in mushrooms from Southern and Western Finland. Proc. 4th Asia-Pacific Symposium on Radiochemistry (APSORC'09), Napa, California, Nov. 29-Dec. 4, 2009.
55 Malmberg M et al. Cardiomyocyte apoptosis after cardioplegic ischemia: Comparison to unprotected regional ischemia-reperfusion.
56 Marjamäki P. Imaging of Dopamine and Serotonin Transporters. Pre-Clinical Studies with Radiotracers for Positron Emission Tomography.
57 Maron E et al. Gender differences in brain serotonin transporter availability in panic disorder.
58 Maunu J et al. Ventricular dilatation in relation to outcome at 2 years of age in very preterm infants: a prospective Finnish cohort study.
59 Miettinen JA et al. Effects of intracoronary injection of autologous bone marrow-derived stem cells on natriuretic peptides and inflammatory markers in patients with acute ST-elevation myocardial infraction .
60 Minn H, Markkola A. Pään ja kaulan alueen syöpien diagnostiikka kuvantamistutkimusten muuttuvassa maailmassa.
61 Minn H, Vihinen P. Melanoma imaging with highly specific PET probes: ready for prime time?
62 Mäenpää M et al. Delta entropy of heart rate variability along with deepening anesthesia.
63 Nekolla SG , Saraste A . Novel F-18-Labeled PET myocardial perfusion tracers: Bench to bedside .
64 Noreika V et al. Consciousness lost and found: Subjective experiences in an unresponsive state.
65 Nucifora G et al. Relationship between obstructive coronary artery disease and abnormal stress testing in patients with paroxysmal or persistent atrial fibrillation.
66 Näsi T et al. Spontaneous hemodynamic oscillations during human sleep and sleep stage transitions characterized with near-infrared spectroscopy.
67 Orava J et al. Different metabolic responses of human brown adipose tissue to activation by cold and insulin .
68 Paterson DI et al. Recent advances in cardiac imaging for patients with heart failure .
69 Perrone-Filardi P et al. Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: . a position statement of the Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology.
70 Regitz-Zagrosek V et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during pregnancy of the European Society of Cardiology.
71 Reiner Z et al. ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
72 Roivainen A et al. Human subject with unexpected biodistribution of [11C]PK11195.
73 Scheinin NM et al. Early detection of Alzheimer disease: 11C-PiB PET in twins discordant for cognitive impairment.
74 Scheinin NM et al. Amyloid imaging as a surrogate marker in clinical trials in Alzheimer's disease.
75 Schlesinger J et al. Isomerism of [64Cu-NOTA-Bn]-labeled radiotracers: Separation of two complex isomers and determination of their interconversion energy barrier using ion pair chromatography.
76 Schrey A et al. Blood pressure and free flap oxygenation in head and neck cancer patients.
77 Seppänen M et al. Positroniemissiotomografian ja tietokonetomografian yhdistelmä syövän diagnostiikassa.
78 Seppänen M et al. Positroniemissiotomografian ja tietokonetomografian yhdistelmä syövän diagnistiikassa.
79 Sherif HM et al. Simplified quantification of myocardial flow reserve with flurpiridaz F 18: Validation with microspheres in a pig model .
80 Silvola JM et al. Uptake of 68gallium in atherosclerotic plaques in LDLR-/- ApoB 100/100 mice.
81 Silvola JMU et al. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
82 Silvola JMU et al. Detection of hypoxia by [18F]EF5 in atheroschlerosis plaques in mice .
83 Sundell J et al. Increased B-type natriuretic peptide concentration is associated with reduced coronary vasoreactivity in patients with dilated cardiomyopathy but not in healthy young subjects .
84 Tahvanainen K et al. Rekka-PET-TT ja valtimoiden laaja-alainen vaskuliitti.
85 Tendera M et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases. Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremiety arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology.
86 Teramoto N et al. Experimental pig model of old myocardial infarction with long survival leading to chronic left ventricular dysfunction and remodeling as evaluated by PET.
87 Tuunanen H, Knuuti J. Metabolic remodelling in human heart failure.
88 Virta JR et al. Cerebral acetylcholinesterase activity is not decreased in MS patients with cognitive impairment.
89 Virtanen J et al. Accelerometer-based method for correcting signal baseline changes caused by motion artifacts in medical near-infrared spectroscopy.
90 Virtanen KA, Nuutila P. Brown adipose tissue in humans.
91 Virtanen S et al. Voxelwise analysis of diffusion tensor imaging and structural MR imaging in patients with the m.3243A>G mutation in mitochondrial DNA.
92 Vähäsilta T et al. Cardiomyocyte apoptosis following antegrade and retrograde cardioplegia during aortic valve surgery.
93 Östberg A et al. Cholinergic dysfunction after traumatic brain injury - preliminary findings from a PET study.
Julkaisutietokanta 23.11.2012 Publications Data Base 23.11.2012